Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 12, 2011; 76 (15) In Focus

Spotlight on the April 12 Issue

Robert A. Gross
First published April 11, 2011, DOI: https://doi.org/10.1212/WNL.0b013e318216e9b7
Robert A. Gross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Spotlight on the April 12 Issue
Robert A. Gross
Neurology Apr 2011, 76 (15) 1283; DOI: 10.1212/WNL.0b013e318216e9b7

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
247

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysisEmbedded Image

The authors analyzed the fluid-attenuated inversion recovery/diffusion-weighted imaging obtained before IV thrombolysis in 115 patients to search for MRI-defined recent silent ischemia (RSI). RSI was identified in 18% of pretreatment MRI; however, the presence of RSI was not associated with an increased risk of asymptomatic or symptomatic hemorrhagic transformation.

See p. 1288, Editorial, p. 1284

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposureEmbedded Image

The authors investigated dopaminergic function using FDOPA PET in 20 asymptomatic, manganese-exposed welders, 20 subjects with idiopathic Parkinson disease, and 20 normal controls. Caudate Kis was lower in welders compared with control subjects, demonstrating that asymptomatic, manganese-exposed welders have a unique pattern of dopaminergic dysfunction.

See p. 1296

From editorialist W.R. Wayne Martin: “The study provides an excellent example of the utility of FDOPA/PET in the assessment of potential dopaminergic changes occurring in asymptomatic individuals. It is important to remember, however, that PD remains a clinical diagnosis centered on the presence of the characteristic neurologic signs.”

See p. 1286

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximabEmbedded ImageEmbedded Image

The authors examined 10 patients with neuromyelitis optica who were treated up to 5 times with rituximab as a second-line therapy. They found that retreatment should be applied before reappearance of circulating B cells and does provide stabilization in most patients.

See p. 1310

fMRI language dominance and FDG-PET hypometabolismEmbedded Image

The authors examined the association of left temporal hypometabolism with laterality of fMRI language task activation in 30 patients with temporal lobe epilepsy. They did not find evidence of impaired BOLD response in hypometabolic cortex. Regional hypometabolism appeared to be a marker for the temporal lobe dysfunction that leads to displacement of language function.

See p. 1322

Long-term intellectual outcome after temporal lobe surgery in childhoodEmbedded Image

The authors report the follow-up of 42 children who underwent temporal lobe surgery. At follow-up, 86% of the surgical group were seizure-free and 57% were no longer taking antiepileptic medication. Developmental catch-up (IQ increment) was seen in children who became seizure-free after neurosurgical treatment.

See p. 1330

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in childrenEmbedded ImageEmbedded ImageEmbedded Image

Gingival overgrowth is a common, cosmetically and medically important adverse effect of phenytoin therapy. This study found significant reduction in the incidence of phenytoin-induced gingival overgrowth in 62 participants receiving daily oral folic acid (0.5 mg/day for 6 months) as compared to a placebo-control group with 58 participants.

See p. 1338

VIEWS & REVIEWS

Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links

This review proposes a conceptual framework involving the amyloid-β peptide, Aβ precursor protein, and fragile X mental retardation protein based on experimental evidence. The authors speculate that the anabolic effect of sAPPα contributes to the state of excess that underlies fragile X syndrome and autism, especially in younger children.

See p. 1344

NB: Reflections for April: “The silent witness and Charcot's hat,” see p. 1358. To check out other Reflections, point your browser to http://www.neurology.org. The Green Journal is celebrating an important anniversary in 2011—it is 60 years old. Check out some of the activities this week at the AAN Meeting.

  • Copyright © 2011 by AAN Enterprises, Inc.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
    • Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure
    • Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
    • fMRI language dominance and FDG-PET hypometabolism
    • Long-term intellectual outcome after temporal lobe surgery in childhood
    • Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
    • VIEWS & REVIEWS
  • Figures & Data
  • Info & Disclosures
Advertisement

Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials

Dr. Nicole Sur and Dr. Mausaminben Hathidara

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Views and Reviews
    Autism, Alzheimer disease, and fragile X
    APP, FMRP, and mGluR5 are molecular links
    D.K. Sokol, B. Maloney, J.M. Long et al.
    Neurology, April 11, 2011
  • Editorial
    Epigenetic diagnostics for neuropsychiatric disorders
    Above the genome
    Stephen J. Haggarty et al.
    Neurology, March 25, 2015
  • Editorial
    Genetics, white matter, and cognition
    The effects of methylation on FMR1

    Paul A. Nyquist, Randi Hagerman et al.
    Neurology, May 05, 2017
  • Editorials
    Executive dysfunction in young FMR1 premutation carriers
    Forme fruste of FXTAS or new phenotype?
    Elizabeth Berry-Kravis, Deborah A. Hall et al.
    Neurology, July 20, 2011
Neurology: 100 (23)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise